105941-9
LaboratoryMultiple myeloma minimal residual disease analysis [Presence] in Bone marrow by NAA with non-probe detection
Definition
This test is to detect the minimal residual disease (MRD) or the small number of Multiple myeloma cancer cells that may remain in a patient's body after treatment and are not detectable using conventional diagnostic methods.
LOINC 6-Axis Classification
Component
Multiple myeloma minimal residual disease analysis
Property
PrThr
Time Aspect
Pt
System
Bone mar
Scale Type
Ord
Method Type
Non-probe.amp.tar
Details
Class
MOLPATH
Order/Observation
Both
Short Name
MM MRD anlyss Mar Ql NAA+n-prb
Display Name
Multiple myeloma minimal residual disease analysis NAA+non-probe Ql (BM)
Related Names
Frequently Asked Questions
What is LOINC code 105941-9?
LOINC code 105941-9 identifies "Multiple myeloma minimal residual disease analysis [Presence] in Bone marrow by NAA with non-probe detection". This test is to detect the minimal residual disease (MRD) or the small number of Multiple myeloma cancer cells that may remain in a patient's body after treatment and are not detectable using conventional diagnostic methods.
What does 105941-9 measure?
This code measures Multiple myeloma minimal residual disease analysis in Bone mar. It belongs to the MOLPATH class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.